Abcam (ABCM)

Abcam (ABCM) Stock Price & Analysis


ABCM Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$12.48 - $25.32
Previous Close$22.69
Average Volume (3M)4.75M
Market Cap
Enterprise Value$5.35B
Total Cash (Recent Filing)£89.00M
Total Debt (Recent Filing)£223.90M
Price to Earnings (P/E)1334.7
Mar 18, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.02
Shares Outstanding229,271,907
10 Day Avg. Volume4,596,899
30 Day Avg. Volume4,748,532
Standard Deviation0.13
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)11.89
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside10.96% Upside
Rating ConsensusHold
Number of Analyst Covering5



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Abcam’s price range in the past 12 months?
Abcam lowest stock price was $12.48 and its highest was $25.32 in the past 12 months.
    What is Abcam’s market cap?
    Currently, no data Available
    When is Abcam’s upcoming earnings report date?
    Abcam’s upcoming earnings report date is Mar 18, 2024 which is in 166 days.
      How were Abcam’s earnings last quarter?
      Abcam released its earnings results on Aug 31, 2023. The company reported $0.203 earnings per share for the quarter, beating the consensus estimate of $0.199 by $0.004.
        Is Abcam overvalued?
        According to Wall Street analysts Abcam’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Abcam pay dividends?
          Abcam does not currently pay dividends.
          What is Abcam’s EPS estimate?
          Abcam’s EPS estimate is $0.24.
            How many shares outstanding does Abcam have?
            Abcam has 229,271,910 shares outstanding.
              What happened to Abcam’s price movement after its last earnings report?
              Abcam reported an EPS of $0.203 in its last earnings report, beating expectations of $0.199. Following the earnings report the stock price went up 0.928%.
                Which hedge fund is a major shareholder of Abcam?
                Currently, no hedge funds are holding shares in ABCM


                Abcam Stock Smart Score

                The Abcam stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description


                Abcam PLC is a biotechnology company that develops and provides antibodies to life science research and clinical communities. The company's products allow research into the role of signaling and regulatory molecules and proteins in biological pathways. Such research ultimately leads to treatments for diseases such as cancer and immune deficiency disorders. Abcam's focused on broadening its product range, improving speed to market, and accessing underpenetrated consumer groups in its markets. The company also selectively pursues partnerships and acquisitions.


                Top 5 ETFs holding ABCM

                Market Value
                Smart Score
                Fidelity Nasdaq Composite Index ETF
                Up to five ETFs with an Outperform Smart Score that hold ABCM. The ETFs are listed according to market value of ABCM within the ETF

                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Abeona Therapeutics
                Abbott Labs
                Arbutus Biopharma
                ACADIA Pharmaceuticals

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis